FDA Recalls Cardioplegia Solution Over Sterility Assurance Concerns
Central Admixture Pharmacy Services is recalling Cardioplegia Solution, Reperfusate 4:1 due to lack of sterility assurance identified during an FDA inspection. The recall affects 338 bags distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for lack of sterility assurance in a compounded pharmaceutical product. No illnesses or injuries are reported in the source text; however, a sterile product that cannot be assured to meet sterility requirements poses a significant safety risk to patients.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Cardioplegia Solution, Reperfusate 4:1 low potassium (15 mEq K), packaged in 477.5 mL bags. This solution is used in cardiac surgery to perfuse and protect the heart during surgical procedures. A total of 338 bags are affected by this recall.
The FDA issued this recall after an inspection raised questions about the sterility of the products intended to be sterile. When a sterile pharmaceutical product cannot be assured to be sterile, it poses a potential risk to patient safety.
The product was distributed nationwide in the United States. The affected lot numbers are 37-893847 (Exp 04/28/2023), 37-895646 (Exp 05/05/2023), 37-897804 (Exp 05/12/2023), and 37-899236 (Exp 05/19/2023). Additional information about this recall is available from Central Admixture Pharmacy Services, Inc., located at 6580 Snowdrift Road, Allentown, PA 18106.
The recalled product
- Product
- Cardioplegia Solution, Reperfusate 4:1 low potassium, 15 mEq K, packaged in 477.5 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0008-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- sterility-failure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot # 37-893847
- Exp 04/28/2023
- 37-895646
- Exp 05/05/2023
- 37-897804
- Exp 05/12/2023
- 37-899236
- Exp 05/19/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27